Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127242271 | 12724227 | 1 | I | 20050111 | 20050218 | 20160908 | 20160908 | EXP | US-VIIV HEALTHCARE LIMITED-US2005000025 | VIIV | HEDAYATI SS AND PATEL V. LACTIC ACIDOSIS IN AN HIV-INFECTED PATIENT RECEIVING HIGHLY ACTIVE ANTIRETROVIRAL THERAPY. NATURE CLINICAL PRACTICE NEPHROLOGY. 2006;2 (2):109 - 115 | 51.53 | YR | M | Y | 56.80000 | KG | 20160908 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127242271 | 12724227 | 1 | SS | VIREAD | TENOFOVIR DISOPROXIL FUMARATE | 1 | Unknown | 300 MG, QD | Y | 0 | 300 | MG | TABLET | QD | |||||
| 127242271 | 12724227 | 2 | PS | ABACAVIR. | ABACAVIR | 1 | Unknown | 300 MG, BID | Y | 20977 | 300 | MG | BID | ||||||
| 127242271 | 12724227 | 3 | SS | LOPINAVIR AND RITONAVIR | LOPINAVIRRITONAVIR | 1 | Unknown | 3 DF, BID | Y | 0 | 3 | DF | BID | ||||||
| 127242271 | 12724227 | 4 | SS | DDI | DIDANOSINE | 1 | Unknown | 400 MG, QD | Y | 0 | 400 | MG | QD | ||||||
| 127242271 | 12724227 | 5 | C | CARISOPRODOL. | CARISOPRODOL | 1 | Oral | 350 MG, TID | 0 | 350 | MG | TABLET | TID | ||||||
| 127242271 | 12724227 | 6 | C | FENTANYL. | FENTANYL | 1 | Transdermal | 25 UG, Q3DAYS | 0 | 25 | UG | ||||||||
| 127242271 | 12724227 | 7 | C | FLUCONAZOLE. | FLUCONAZOLE | 1 | Oral | 200 MG, QD | 0 | 200 | MG | TABLET | QD | ||||||
| 127242271 | 12724227 | 8 | C | GLYBURIDE. | GLYBURIDE | 1 | Oral | 2.5 MG, QD | 0 | 2.5 | MG | TABLET | QD | ||||||
| 127242271 | 12724227 | 9 | C | PROMETHAZINE | PROMETHAZINEPROMETHAZINE HYDROCHLORIDE | 1 | 12.5 MG, PRN | 0 | 12.5 | MG | TABLET | ||||||||
| 127242271 | 12724227 | 10 | C | RABEPRAZOLE | RABEPRAZOLE | 1 | Oral | 20 MG, BID | 0 | 20 | MG | TABLET | BID | ||||||
| 127242271 | 12724227 | 11 | C | RABEPRAZOLE | RABEPRAZOLE | 1 | 0 | TABLET | |||||||||||
| 127242271 | 12724227 | 12 | C | BACTRIM DS | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Oral | 1 DF, QD | 0 | 1 | DF | TABLET | QD | ||||||
| 127242271 | 12724227 | 13 | C | LORATADINE. | LORATADINE | 1 | Oral | 10 MG, QD | 0 | 10 | MG | TABLET | QD | ||||||
| 127242271 | 12724227 | 14 | C | LORTAB | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | 0 | ||||||||||||
| 127242271 | 12724227 | 15 | C | LORAZEPAM. | LORAZEPAM | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127242271 | 12724227 | 1 | HIV infection |
| 127242271 | 12724227 | 2 | HIV infection |
| 127242271 | 12724227 | 3 | HIV infection |
| 127242271 | 12724227 | 4 | HIV infection |
| 127242271 | 12724227 | 5 | Muscle relaxant therapy |
| 127242271 | 12724227 | 6 | Pain |
| 127242271 | 12724227 | 7 | Fungal infection |
| 127242271 | 12724227 | 10 | Gastrooesophageal reflux disease |
| 127242271 | 12724227 | 11 | Ulcer |
| 127242271 | 12724227 | 12 | Infection |
| 127242271 | 12724227 | 13 | Hypersensitivity |
| 127242271 | 12724227 | 14 | Pain |
| 127242271 | 12724227 | 15 | Psychogenic seizure |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127242271 | 12724227 | OT |
| 127242271 | 12724227 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127242271 | 12724227 | Fanconi syndrome acquired | |
| 127242271 | 12724227 | Hepatitis | |
| 127242271 | 12724227 | Lactic acidosis | |
| 127242271 | 12724227 | Pancreatitis | |
| 127242271 | 12724227 | Renal tubular acidosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127242271 | 12724227 | 1 | 20020118 | 20050116 | 0 | |
| 127242271 | 12724227 | 2 | 20020118 | 20050116 | 0 | |
| 127242271 | 12724227 | 3 | 20020118 | 20050116 | 0 | |
| 127242271 | 12724227 | 4 | 20020118 | 20050116 | 0 |